05:03 PM EDT, 05/10/2024 (MT Newswires) -- Richard Scott Struthers, Director, President & CEO, on May 08, 2024, sold 107,448 shares in Crinetics Pharmaceuticals ( CRNX ) for $5,307,931. Following the Form 4 filing with the SEC, Struthers has control over a total of 1,159,290 shares of the company, with 257,485 shares held directly and 901,805 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000095017024057926/xslF345X03/ownership.xml